PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
10.64%
Revenue growth at 75-90% of RUN's 12.90%. Bill Ackman would push for innovation or market expansion to catch up.
-69.23%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
578.63%
EBIT growth above 1.5x RUN's 23.91%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
41.20%
Operating income growth above 1.5x RUN's 0.47%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
-149.44%
Negative net income growth while RUN stands at 460.66%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-150.00%
Negative EPS growth while RUN is at 456.14%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-150.00%
Negative diluted EPS growth while RUN is at 436.85%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.43%
Share reduction more than 1.5x RUN's 1.22%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
-0.94%
Reduced diluted shares while RUN is at 1.26%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-459.13%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-402.94%
Negative FCF growth while RUN is at 156.78%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
331.84%
10Y revenue/share CAGR 1.25-1.5x RUN's 231.43%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
331.84%
5Y revenue/share CAGR above 1.5x RUN's 64.82%. David Dodd would look for consistent product or market expansions fueling outperformance.
73.83%
Positive 3Y CAGR while RUN is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
-165.78%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-165.78%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-1141.78%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
81.92%
Below 50% of RUN's 1473.60%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
81.92%
Below 50% of RUN's 1185.12%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
8.58%
Below 50% of RUN's 220.80%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
77.44%
Positive short-term equity growth while RUN is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-5.89%
Firm’s AR is declining while RUN shows 8.37%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
5.78%
Inventory shrinking or stable vs. RUN's 18.52%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
4.06%
Similar asset growth to RUN's 4.18%. Walter Schloss finds parallel expansions or investment rates.
2.53%
Under 50% of RUN's 11.80%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-12.08%
We’re deleveraging while RUN stands at 3.38%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
7.68%
We increase R&D while RUN cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
25.74%
We expand SG&A while RUN cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.